Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rixing Bio-Tech

Explore full profile

APIs, dyestuffs, and fine chemical product manufacturing

Yangzhou, ChinaFounded 2004
Revenue $88M Latest reported FY

About Rixing Bio-Tech

Yangzhou Rixing Bio-Tech Co., Ltd., established in 2004, is a high-tech enterprise based in Gaoyou Industrial Park, Yangzhou, China, that develops, produces, and sells dyes, dye intermediates, digital printing inks, and glucosamine biological products. The company's main product lines include anthraquinone dyes and intermediates, disperse dyes, and a D-glucosamine series.

The company operates as a manufacturer and trading company, serving various sectors with products like D-glucosamine hydrochloride, chondroitin sulfate, and chitosan series, which are used as active pharmaceutical ingredients (APIs) and in finished products like tablets and capsules. These ingredients have physiological applications, including supporting liver and kidney detoxification and the treatment of rheumatoid arthritis. In addition to biopharmaceuticals, Rixing Bio-Tech produces a range of chemical products, including disperse dyes for inks and various dye intermediates.

Rixing Bio-Tech has established significant research and development capabilities, hosting a "National Postdoctoral Research Workstation" and the "Jiangsu Provincial Chitin Deep Processing Engineering Technology Research Center." It maintains long-term technical cooperation with several universities and research institutes. The company has undertaken numerous national and provincial research projects and holds a significant number of patents. It has received multiple certifications, including ISO9001, and has been recognized as a National "Specialized, Refined, New" Little Giant Enterprise.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2004
Headquarters
Yangzhou, China
Listing
IPO 2016

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Tronfund
  • Jinyu Maowu Investment
Employees 6 total headcount
Founders Hidden β€” book a demo/100 quality score
Key operators Hidden β€” book a demo quality score
Potential founders Hidden β€” book a demo likely future founders
Startup mafia Hidden β€” book a demo alumni-founded startups
Talent movements Hidden β€” book a demo in Β· Hidden β€” book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
πŸ‡¨πŸ‡³ China Β· Yangzhou HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rixing Bio-Tech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X β€” pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) Β· Synthesis by Claude Β· Cached for 1 hour

See Rixing Bio-Tech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.